Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma Inc. (BBIO)(BBIO) | 6,089,611 | 5,089,611 | -1,000,000 | 316,294 | 389,304 | 81.29% | +73,010 |
| Monte Rosa Therapeutics Inc (GLUE)(GLUE) | 1,472,331 | 1,472,331 | 0 | 10,910 | 23,086 | 4.82% | +12,176 |
| Syndax Pharmaceuticals, Inc. (SNDX)(SNDX) | 1,316,806 | 1,316,806 | 0 | 20,266 | 27,666 | 5.78% | +7,400 |
| Urogen Pharma Ltd. (URGN)(URGN) | 0 | 108,000 | +108,000 | 0 | 2,529 | 0.53% | +2,529 |
| CalciMedica, Inc. (CALC)(CALC) | 521,114 | 521,114 | 0 | 1,603 | 3,434 | 0.72% | +1,831 |
| Compass Pathways Plc (CMPS)(CMPS) | 1,198,418 | 1,198,418 | 0 | 6,867 | 8,269 | 1.73% | +1,402 |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | 8,983 | 9,575 | 2.00% | +592 |
| BridgeBio Oncology Therapeutics (BBOT)(BBOT) | 564,625 | 564,625 | 0 | 6,538 | 7,069 | 1.48% | +531 |
| Scholar Rock Holding Corporation (SRRK)(SRRK) | 77,031 | 77,031 | 0 | 2,869 | 3,393 | 0.71% | +525 |
| Aclaris Therapeutics Inc (ACRS)(ACRS) | 434,455 | 434,455 | 0 | 825 | 1,308 | 0.27% | +482 |
| Marker Therapeutics, Inc. (MRKR)(MRKR) | 325,370 | 325,370 | 0 | 290 | 485 | 0.10% | +194 |
| OnKure Therapeutics, Inc. (OKUR)(OKUR) | 88,607 | 88,607 | 0 | 244 | 257 | 0.05% | +13 |
| Biomea Fusion Inc (BMEA)(BMEA) | 2,048,757 | 2,048,757 | 0 | 4,138 | 2,540 | 0.53% | -1,598 |
| Nuvation Bio Inc. (NUVB)(NUVB) | 2,960,659 | 0 | -2,960,659 | 10,954 | 0 | — | -10,954 |
| Verona Pharma plc (VRNA) | 615,352 | 0 | -615,352 | 65,664 | 0 | — | -65,664 |